跳至主要内容
临床试验/NCT01442818
NCT01442818已完成不适用

Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery: A Randomized Trial Comparing Patient-Controlled Intravenous Analgesia (PCA) to Scheduled Intravenous Analgesia

TriHealth Inc.1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2010年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
1
主要终点
Patient Pain Control

研究概览

简要总结

The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery.

详细描述

The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery.

In order to determine if there is a significant correlation, secondary outcomes will include the daily and total narcotic volume used, common side effects from the opioid including nausea, vomiting, or pruritis, length of hospital stay, timing of flatus and first bowel movement, all complications, and procedure performed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The patients will be limited to those from the Division of Urogynecology to ensure similar surgical techniques. They will be between the ages of 18 and 70 and undergoing major vaginal reconstruction.
  • All patients must undergo vaginal reconstructive surgery including: anterior repair, posterior repair, and intraperitoneal vaginal vault suspension. The addition of vaginal hysterectomy, enterocele repair, or suburethral sling is not cause for exclusion.

排除标准

  • Any patient who has an allergy to hydromorphone/Dilaudid.
  • Any patient already taking chronic opioids, defined as daily use.
  • All patients with renal insufficiency or failure.
  • All patients with liver failure.
  • Any patient who is not having general anesthesia.
  • Any patient undergoing abdominal or laparoscopic procedures: sacral colpopexy, laparoscopic hysterectomy or oophorectomy, Burch procedure, or any procedure that enters the abdominal fascia.

研究组 & 干预措施

Scheduled IV post op

Experimental

Patient's will receive scheduled nurse administered IV pain medications post operatively.

干预措施: Dilaudid IV Scheduled (Drug)

PCA post op

Experimental

Patients will receive PCA for pain control post operatively.

干预措施: Dilaudid PCA (Drug)

结局指标

主要结局

Patient Pain Control

时间窗: post operative day 1

Patient's reported pain on a VAS on all postoperative day one.

次要结局

  • Patient Satisfaction with Pain Control(post operative day 1)
  • patient perceived pain at 2 weeks(2 weeks post op)
  • patient dissatisfaction with pain control at 2 weeks(2 weeks post op)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验